首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   50908篇
  免费   3225篇
  国内免费   283篇
耳鼻咽喉   444篇
儿科学   1490篇
妇产科学   1292篇
基础医学   6794篇
口腔科学   1247篇
临床医学   4947篇
内科学   11308篇
皮肤病学   1100篇
神经病学   5319篇
特种医学   1572篇
外科学   6434篇
综合类   200篇
一般理论   21篇
预防医学   3952篇
眼科学   945篇
药学   3206篇
  1篇
中国医学   113篇
肿瘤学   4031篇
  2024年   80篇
  2023年   604篇
  2022年   1161篇
  2021年   2092篇
  2020年   1223篇
  2019年   1723篇
  2018年   1938篇
  2017年   1353篇
  2016年   1500篇
  2015年   1752篇
  2014年   2402篇
  2013年   2999篇
  2012年   4498篇
  2011年   4490篇
  2010年   2248篇
  2009年   2081篇
  2008年   3497篇
  2007年   3387篇
  2006年   3058篇
  2005年   2987篇
  2004年   2528篇
  2003年   2224篇
  2002年   1975篇
  2001年   239篇
  2000年   166篇
  1999年   259篇
  1998年   329篇
  1997年   239篇
  1996年   212篇
  1995年   190篇
  1994年   164篇
  1993年   129篇
  1992年   92篇
  1991年   78篇
  1990年   66篇
  1989年   45篇
  1988年   42篇
  1987年   34篇
  1986年   32篇
  1985年   36篇
  1984年   42篇
  1983年   20篇
  1982年   41篇
  1981年   28篇
  1980年   27篇
  1979年   12篇
  1978年   14篇
  1977年   13篇
  1976年   10篇
  1972年   9篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Technologies for diabetes management, such as continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems, have improved remarkably over the last decades. These developments are impacting the capacity to achieve recommended hemoglobin A1c levels and assisting in preventing the development and progression of micro- and macro vascular complications. While improvements in metabolic control and decreases in risk of severe and moderate hypoglycemia have been described with use of these technologies, large epidemiological international studies show that many patients are still unable to meet their glycemic goals, even when these technologies are used. This editorial will review the impact of technology on glycemic control, hypoglycemia and quality of life in children and youth with type 1 diabetes. Technologies reviewed include CSII, CGM systems and sensor-augmented insulin pumps. In addition, the usefulness of advanced functions such as bolus profiles, bolus calculators and threshold-suspend features will be also discussed. Moreover, the current editorial will explore the challenges of using these technologies. Indeed, despite the evidence currently available of the potential benefits of using advanced technologies in diabetes management, many patients still report barriers to using them. Finally this article will highlight the importance of future studies tailored toward overcome these barriers to optimizing glycemic control and avoiding severe hypoglycemia.  相似文献   
32.
33.
A series of three World Café events centred on the topic of developing an Educational Framework for Urological Nursing [EFUN] were held by the British Association of Urological Nurses [BAUN], the European Association of Urology Nurses [EAUN] and the Australian and New Zealand Urological Nursing Society [ANZUNS] between 2017 and 2019. About 376 urology nurses participated in these “conversations that matter” and generated 1047 individual response items that were grouped into themes to assist the three associations to take the creation of an EFUN to the next level. Areas explored centred on four aspects: what any agreed educational framework for urology nursing should contain; the academic level at which education should be provided; who should be recruited as collaborators on writing an educational framework and, lastly, just how any emergent framework should be used. Analysis of the conversational data indicate that there exists within the urological nursing community a collective wisdom regarding their educational needs and how these needs should be met.  相似文献   
34.
35.
36.
37.
38.

Background

Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.

Patients and Methods

We conducted a multicenter retrospective analysis in the Triveneto region of Italy.

Results

One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.

Conclusion

This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined.  相似文献   
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号